Innovus Pharma Initiates Primate Safety Studies of Its Products That Affect Premature Ejaculation and Penile Sensation
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
LA JOLLA, Calif., July 3, 2013 (GLOBE NEWSWIRE) -- Innovus Pharmaceuticals Inc., ("Innovus Pharma") www.innovuspharma.com (OTCBB:INNV) today announced it started two studies in non-human primates to evaluate the safety of daily use of EjectDelay and CIRCUMserum.
Help employers find you! Check out all the jobs and post your resume.
LA JOLLA, Calif., July 3, 2013 (GLOBE NEWSWIRE) -- Innovus Pharmaceuticals Inc., ("Innovus Pharma") www.innovuspharma.com (OTCBB:INNV) today announced it started two studies in non-human primates to evaluate the safety of daily use of EjectDelay and CIRCUMserum.
Help employers find you! Check out all the jobs and post your resume.